Kim Tae Gyu
Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
Radiat Oncol J. 2017 Dec;35(4):359-367. doi: 10.3857/roj.2017.00388. Epub 2017 Dec 20.
This study sought to identify potential candidates for adjuvant radiotherapy and patterns of regional failure in patients who underwent curative-intent surgery for gallbladder cancer.
Records for 70 patients with gallbladder cancer who underwent curative resection at a single institution between 2000 and 2016 were analysed retrospectively. No patients received adjuvant radiotherapy. Initial patterns of failure were evaluated. Regional recurrence was categorized according to the definitions of lymph node stations suggested by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Median follow-up was 23 months. Locoregional recurrence as any component of first failure occurred in 29 patients (41.4%), with isolated locoregional recurrence in 13 (18.6%). Regional recurrence occurred in 23 patients, and 77 regional recurrences were identified. Commonly involved regional stations were #13, #12a2, #12p2, #12b2, #16a2, #16b1, #9, and #8. Independent prognostic factors for locoregional recurrence were ≥pT2 disease (hazard ratio [HR], 5.510; 95% confidence interval [CI], 1.260-24.094; p = 0.023) and R1 resection (HR, 6.981; 95% CI, 2.378-20.491; p < 0.001).
Patients with pT2 disease or R1 resection after curative surgery for gallbladder cancer may benefit from adjuvant radiotherapy. Our findings on regional recurrence may help physicians construct a target volume for adjuvant radiotherapy.
本研究旨在确定接受胆囊癌根治性手术患者辅助放疗的潜在候选者以及区域复发模式。
回顾性分析了2000年至2016年间在单一机构接受根治性切除的70例胆囊癌患者的记录。无患者接受辅助放疗。评估初始失败模式。根据日本肝胆胰外科学会建议的淋巴结分站定义对区域复发进行分类。
中位随访时间为23个月。29例患者(41.4%)首次出现局部区域复发,其中孤立性局部区域复发13例(18.6%)。23例患者发生区域复发,共识别出77次区域复发。常见受累区域分站为#13、#12a2、#12p2、#12b2、#16a2、#16b1、#9和#8。局部区域复发的独立预后因素为≥pT2期疾病(风险比[HR],5.510;95%置信区间[CI],1.260 - 24.094;p = 0.023)和R1切除(HR,6.981;95%CI,2.378 - 20.491;p < 0.001)。
胆囊癌根治性手术后患有pT2期疾病或R1切除的患者可能从辅助放疗中获益。我们关于区域复发的研究结果可能有助于医生构建辅助放疗的靶区体积。